SBC Medical Group Holdings (SBC)
NASDAQ:SBC
SBC Stock Chart & Stats
$4.47
$0.07(1.30%)
At close: 4:00 PM EST
$4.47
$0.07(1.30%)
Day’s Range― - ―
52-Week Range$2.91 - $5.75
Previous CloseN/A
Volume6.18K
Average Volume (3M)65.67K
Market Cap
$428.77M
Enterprise Value$316.63M
Total Cash (Recent Filing)$164.09M
Total Debt (Recent Filing)$51.64M
Price to Earnings (P/E)7.8
Beta0.65
Next Earnings
May 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.14
Shares Outstanding102,576,940
10 Day Avg. Volume48,167
30 Day Avg. Volume65,672
Financial Highlights & Ratios
PEG Ratio2.43
Price to Book (P/B)1.79
Price to Sales (P/S)2.56
P/FCF Ratio12.15
Enterprise Value/Market Cap0.74
Enterprise Value/Revenue1.82
Enterprise Value/Gross Profit2.50
Enterprise Value/Ebitda4.00
Forecast
1Y Price Target
$8.50Price Target Upside90.16% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.45
Revenue Forecast (FY)$182.92M
Bulls Say, Bears Say
Bulls Say
Profitability & MarginsSBC’s sustained high net margins and rising absolute net income create a durable earnings cushion that supports reinvestment, organic expansion and shareholder returns. Strong profitability reduces dependence on external funding and helps absorb near-term top-line volatility while the company executes strategy.
Balance Sheet CapacityHistorically conservative leverage and a sizable equity base give SBC meaningful financial flexibility to fund M&A, international expansion or product investments. Even with higher 2025 debt, balance-sheet capacity supports disciplined scaling and buffers against cyclical pressures for the next several quarters.
Strategic Growth Initiatives & Customer BaseWellness 2.0 and the U.S. minority investment broaden SBC’s addressable market from aesthetics into longevity and international aesthetics. A large, repeat customer base and clinic footprint create recurring revenue potential and data assets that support cross-selling, higher lifetime value and durable growth tailwinds.
Bears Say
Revenue ContractionA 15% top-line decline reflects a structural demand reset tied to 2024 restructuring and 2025 franchise fee revisions. Persistent or repeated revenue weakness would limit the company’s ability to scale new initiatives and compress operating leverage, making revenue recovery a key multi-quarter execution risk.
Cash-Flow VolatilityInconsistent conversion of earnings into operating cash and volatile free cash flow constrain internal funding for expansion, M&A or buybacks. Over a 2–6 month horizon, unstable cash generation raises execution risk and could force reliance on external financing precisely when investment is needed for strategic initiatives.
Rising Leverage & Dilution RiskAn uptick in debt alongside an active $50M equity shelf creates a dual financing overhang: higher leverage can stress interest and covenant headroom, while use of the shelf could dilute shareholders. Both dynamics reduce capital-allocation optionality during the important multi-quarter growth re-acceleration phase.
SBC Medical Group Holdings News
SBC FAQ
What was SBC Medical Group Holdings’s price range in the past 12 months?
SBC Medical Group Holdings lowest stock price was $2.91 and its highest was $5.75 in the past 12 months.
What is SBC Medical Group Holdings’s market cap?
SBC Medical Group Holdings’s market cap is $428.77M.
When is SBC Medical Group Holdings’s upcoming earnings report date?
SBC Medical Group Holdings’s upcoming earnings report date is May 14, 2026 which is in 42 days.
How were SBC Medical Group Holdings’s earnings last quarter?
SBC Medical Group Holdings released its earnings results on Mar 27, 2026. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.12 by $0.02.
Is SBC Medical Group Holdings overvalued?
According to Wall Street analysts SBC Medical Group Holdings’s price is currently Undervalued.
Does SBC Medical Group Holdings pay dividends?
SBC Medical Group Holdings does not currently pay dividends.
What is SBC Medical Group Holdings’s EPS estimate?
SBC Medical Group Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SBC Medical Group Holdings have?
SBC Medical Group Holdings has 102,576,940 shares outstanding.
What happened to SBC Medical Group Holdings’s price movement after its last earnings report?
SBC Medical Group Holdings reported an EPS of $0.14 in its last earnings report, beating expectations of $0.12. Following the earnings report the stock price went up 4.211%.
Which hedge fund is a major shareholder of SBC Medical Group Holdings?
Currently, no hedge funds are holding shares in SBC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SBC Medical Group Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.50 (90.16% Upside)
$8.50 (90.16% Upside)
Hedge Fund Trend
Decreased
By 200.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $9.4M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-44.06%
12-Months-Change
Fundamentals
Return on Equity
21.08%
Trailing 12-Months
Asset Growth
42.98%
Trailing 12-Months
Company Description
SBC Medical Group Holdings
SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally. The company offers advertising and marketing services; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals and facility rentals; construction and design of franchisee clinics; medical equipment; and medical consumables procurement. It provides IT software solutions; breast augmentation, liposuction, and rejuvenation treatments, including treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. The company was founded in 2000 and is headquartered in Irvine, California.
SBC Company Deck
SBC Earnings Call
Q4 2026
0:00 / 0:00
SBC Stock 12 Month Forecast
Average Price Target
$8.50
▲(90.16% Upside)
Technical Analysis
Cra International
―
Forrester Research
―
Franklin Covey Company
―
Resources Connection
―
Aeries Technology
―
Ownership Overview
86.05% Insiders
0.37% Mutual Funds
0.01% Other Institutional Investors
13.05% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---